|
|
|
This is the preliminary program for the 2008 Joint Statistical
Meetings in Denver, Colorado.
|
|
|
The views expressed here are those of the individual authors and not necessarily those of the ASA or its board, officers, or staff. Back to main JSM 2008 Program page |
= Applied Session,
= Theme Session,
= Presenter|
|
||
225
|
Tue, 8/5/08, 8:30 AM - 10:20 AM | CC-603 |
| Statistical Issues in Biomarker and Imaging Studies - Topic Contributed - Papers | ||
|
Section on Statistics in Epidemiology, Biopharmaceutical Section, Biometrics Section |
||
| Organizer(s): Estelle Russek-Cohen, U.S. Food and Drug Administration | ||
| Chair(s): Lori E. Dodd, National Cancer Institute | ||
| 8:35 AM |
Regulatory Issues Related to the Evaluation of Biomarkers in a Clinical Study —  Kyunghee K. Song, U.S. Food and Drug Administration
|
|
| 8:55 AM |
Capturing Performance of Prognostic Markers: An Overview — Estelle Russek-Cohen, U.S. Food and Drug Administration; Harry F. Bushar, U.S. Food and Drug Administration; Iram Quraishi, U.S. Food and Drug Administration
|
|
| 9:15 AM |
Diagnostic Assays for Screening or Prognosis with Small Biomarker Panels — Friedemann Krause, Roche Diagnostics GmbH
|
|
| 9:35 AM |
Existing Problems in Gene Expression Microarray-Based Assays for Clinical Practice — Samir Lababidi, U.S. Food and Drug Administration
|
|
| 9:55 AM |
Maximum Likelihood Estimators for Fraction of False Negative Lesions when Radiologist Panel Is Non-Unanimous — Arkendra De, U.S. Food and Drug Administration; Gene Pennello, U.S. Food and Drug Administration
|
|
| 10:15 AM | Floor Discussion | |
|
JSM 2008
For information, contact jsm@amstat.org
or phone (888) 231-3473. If you have questions about the Continuing Education program,
please contact the Education Department. |